Cargando…

PKC downregulation upon rapamycin treatment attenuates mitochondrial disease

Leigh syndrome is a fatal neurometabolic disorder caused by defects in mitochondrial function. mTOR inhibition with rapamycin attenuates disease progression in a mouse model of Leigh syndrome (Ndufs4 KO mouse); however, the mechanism of rescue is unknown. Here we identify PKC downregulation as a key...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin-Perez, Miguel, Grillo, Anthony S., Ito, Takashi K., Valente, Anthony S., Han, Jeehae, Entwisle, Samuel W., Huang, Heather Z., Kim, Dayae, Yajima, Masanao, Kaeberlein, Matt, Villén, Judit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017771/ https://www.ncbi.nlm.nih.gov/pubmed/33324011 http://dx.doi.org/10.1038/s42255-020-00319-x

Ejemplares similares

Protein Kinase C Downregulation upon Rapamycin Treatment Attenuates Neuroinflammation and Mitochondrial Disease
por: Grillo, Anthony, et al.
Publicado: (2020)

Decoding Post-Translational Modification Crosstalk With Proteomics
por: Leutert, Mario, et al.
Publicado: (2021)

Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice
por: Bitto, Alessandro, et al.
Publicado: (2016)

Rapamycin in aging and disease: maximizing efficacy while minimizing side effects
por: Johnson, Simon C., et al.
Publicado: (2016)

Rapamycin enhances survival in a Drosophila model of mitochondrial disease
por: Wang, Adrienne, et al.
Publicado: (2016)

Acarbose suppresses symptoms of mitochondrial disease in a mouse model of Leigh Syndrome
por: Bitto, Alessandro, et al.
Publicado: (2020)

Evaluation of off-label rapamycin use to promote healthspan in 333 adults
por: Kaeberlein, Tammi L., et al.
Publicado: (2023)

LEVERAGING THE NDUFS4-/- MOUSE AS A PLATFORM FOR TESTING LONGEVITY INTERVENTIONS
por: Bitto, Alessandro, et al.
Publicado: (2022)

Rapamycin rejuvenates oral health in aging mice
por: An, Jonathan Y, et al.
Publicado: (2020)

Impact of PKCε downregulation on autophagy in glioblastoma cells
por: Toton, Ewa, et al.
Publicado: (2018)

Overexpressed PKCδ Downregulates the Expression of PKCα in B16F10 Melanoma: Induction of Apoptosis by PKCδ via Ceramide Generation
por: Halder, Kuntal, et al.
Publicado: (2014)

Protocatechuic acid attenuates isoproterenol-induced cardiac hypertrophy via downregulation of ROCK1–Sp1–PKCγ axis
por: Bai, Liyan, et al.
Publicado: (2021)

Genetic signature of human longevity in PKC and NF‐κB signaling
por: Ryu, Seungjin, et al.
Publicado: (2021)

Surviving rapamycin
por: Van Epps, Heather L.
Publicado: (2005)

CLINICAL TRIALS IN GEROSCIENCE
por: Kaeberlein, Matt, et al.
Publicado: (2019)

Rapamycin attenuates pathological hypertrophy caused by an absence of trabecular formation
por: Fleming, Nicole D., et al.
Publicado: (2018)

Rapamycin potentiates cytotoxicity by docetaxel possibly through downregulation of Survivin in lung cancer cells
por: Niu, Huiyan, et al.
Publicado: (2011)

Rapamycin downregulates α-klotho in the kidneys of female rats with normal and reduced renal function
por: Espartero, Azahara, et al.
Publicado: (2023)

Absence of PKC-Alpha Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus
por: Sim, Jae H., et al.
Publicado: (2014)

PKCα and PKCδ: Friends and Rivals
por: Black, Jennifer D., et al.
Publicado: (2022)

SOX9-regulated cell plasticity in colorectal metastasis is attenuated by rapamycin
por: Carrasco-Garcia, Estefania, et al.
Publicado: (2016)

Rapamycin Attenuates Acute Seizure-induced Astrocyte Injury in Mice in Vivo
por: Guo, Dongjun, et al.
Publicado: (2017)

Rapamycin downregulates thymidylate synthase and potentiates the activity of pemetrexed in non-small cell lung cancer
por: Kawabata, Shigeru, et al.
Publicado: (2014)

Attenuation of PKCδ enhances metabolic activity and promotes expansion of blood progenitors
por: Rao, Tata Nageswara, et al.
Publicado: (2018)

Differential Roles of the PKC Novel Isoforms, PKCδ and PKCε, in Mouse and Human Platelets
por: Pears, Catherine J., et al.
Publicado: (2008)

Genomics and Genetics of Aging
por: Kaeberlein, Matt
Publicado: (2012)

Longevity and aging
por: Kaeberlein, Matt
Publicado: (2013)

Deciphering the role of natural variation in age-related protein homeostasis
por: Kaeberlein, Matt
Publicado: (2013)

mTOR Inhibition: From Aging to Autism and Beyond
por: Kaeberlein, Matt
Publicado: (2013)

Genome-wide approaches to understanding human ageing
por: Kaeberlein, Matt
Publicado: (2006)

PRESIDENTIAL SYMPOSIUM: EXPANDING THE GEROSCIENCE NETWORK
por: Kaeberlein, Matt
Publicado: (2019)

Biological Sciences Section Perspective
por: Kaeberlein, Matt
Publicado: (2020)

Pharmacological Interventions That Target Biological Aging
por: Kaeberlein, Matt
Publicado: (2020)

Companion dogs to test longevity interventions
por: Kaeberlein, Matt
Publicado: (2020)

Hepatic S6K1 Partially Regulates Lifespan of Mice with Mitochondrial Complex I Deficiency
por: Ito, Takashi K., et al.
Publicado: (2017)

Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
por: Ozcelik, Sefika, et al.
Publicado: (2013)

Multi-Scale Optical Imaging of the Delayed Type Hypersensitivity Reaction Attenuated by Rapamycin
por: Luo, Meijie, et al.
Publicado: (2014)

Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures
por: Yang, Ming-Tao, et al.
Publicado: (2017)

Rapamycin Enhances Mitophagy and Attenuates Apoptosis After Spinal Ischemia-Reperfusion Injury
por: Li, Qiang, et al.
Publicado: (2018)

Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK
por: Filippone, Scott M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fid448hjakd21jqr432oroa490